Breast cancer

ALCINA-4 (IC 2020-11)

Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4
  • Open at Paris since : 23/09/2022
  • Open at Saint-Cloud since : 18/05/2022
  • Target : Adult
  • Phase : Clinical trial

Trial description

Multi-cohort exploratory prospective study. Participation in the ALCINA 4 study does not change the standard management of the patient, including the treatments administered. A sampling schedule will be set up for each cohort.;Depending on the clinical context studied and the biomarkers studied and/or sought, the timing of blood samples will vary between cohorts. There may be up to 4 samples taken per patient for up to 12 or 18 months. If a specific tumor sample is required, it will be collected only once during the Study.
Url of the trial

Main investigators

FRANCOIS-CLEMENT BIDARD

Professeur - Médecin

Contact